成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 360575-29-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 360575-29-7
Chemical Structure| 360575-29-7
Structure of 360575-29-7 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 360575-29-7 ]

Related Doc. of [ 360575-29-7 ]

Alternatived Products of [ 360575-29-7 ]
Product Citations

Product Details of [ 360575-29-7 ]

CAS No. :360575-29-7 MDL No. :MFCD07371547
Formula : C10H7BrO2S Boiling Point : -
Linear Structure Formula :- InChI Key :AOQIBJZMRMVKSH-UHFFFAOYSA-N
M.W : 271.13 Pubchem ID :22473901
Synonyms :

Calculated chemistry of [ 360575-29-7 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.1
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 60.8
TPSA : 54.54 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.24 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.71
Log Po/w (XLOGP3) : 3.82
Log Po/w (WLOGP) : 3.45
Log Po/w (MLOGP) : 2.96
Log Po/w (SILICOS-IT) : 4.14
Consensus Log Po/w : 3.42

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -4.27
Solubility : 0.0145 mg/ml ; 0.0000535 mol/l
Class : Moderately soluble
Log S (Ali) : -4.66
Solubility : 0.00592 mg/ml ; 0.0000218 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -4.27
Solubility : 0.0145 mg/ml ; 0.0000536 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.25

Safety of [ 360575-29-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 360575-29-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 360575-29-7 ]

[ 360575-29-7 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 360575-28-6 ]
  • [ 2365-48-2 ]
  • [ 360575-29-7 ]
YieldReaction ConditionsOperation in experiment
89% With potassium carbonate In N,N-dimethyl-formamide at 60℃; for 15 h; General procedure: To a stirred solution of compound 1a-1n (9.90 mmol) in DMF (20 mL) were added methyl thioglycolate (10.9 mmol) and potassium carbonate (39.6 mmol). The resulting mixture was stirred at 60 °C for 15 h. The DMF was removed under reduced pressure,water (50 mL) was added and the mixture was extracted with ethylacetate (2 x 40 mL). The combined organic layers were dried withsodium sulfate, filtered, and the solvents were removed under reduced pressure to afford the title compound 2a-2n [31,34]. 4.1.1.1. Methyl 4-bromobenzo[b]thiophene-2-carboxylate (2a).Yield 89percent, white solid; m. p. 77-78 °C; 1H NMR (600 MHz,DMSO?d6) δ 8.12 (d, J = 8.2 Hz, 1H), 8.01 (d, J = 0.6 Hz, 1H), 7.73 (d,J = 7.7 Hz, 1H), 7.46 (t, J = 7.9 Hz, 1H), 3.91 (s, 3H).
Reference: [1] European Journal of Medicinal Chemistry, 2019, p. 236 - 251
[2] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 12, p. 2998 - 3001
[3] Patent: US2003/166628, 2003, A1,
[4] Patent: EP1724277, 2006, A1, . Location in patent: Page/Page column 28-29
[5] ACS Medicinal Chemistry Letters, 2015, vol. 6, # 9, p. 1010 - 1014
  • 2
  • [ 1073-06-9 ]
  • [ 360575-29-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 12, p. 2998 - 3001
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 360575-29-7 ]

Bromides

Chemical Structure| 360576-01-8

[ 360576-01-8 ]

Methyl 6-bromobenzo[b]thiophene-2-carboxylate

Similarity: 0.90

Chemical Structure| 550998-53-3

[ 550998-53-3 ]

Methyl 7-bromobenzo[b]thiophene-2-carboxylate

Similarity: 0.84

Chemical Structure| 5118-13-8

[ 5118-13-8 ]

4-Bromobenzo[b]thiophene

Similarity: 0.70

Chemical Structure| 1024594-86-2

[ 1024594-86-2 ]

4,6-Dibromothieno[3,4-b]thiophene-2-carboxylic acid

Similarity: 0.67

Chemical Structure| 62224-16-2

[ 62224-16-2 ]

Methyl 4-bromothiophene-2-carboxylate

Similarity: 0.67

Esters

Chemical Structure| 360576-01-8

[ 360576-01-8 ]

Methyl 6-bromobenzo[b]thiophene-2-carboxylate

Similarity: 0.90

Chemical Structure| 550998-53-3

[ 550998-53-3 ]

Methyl 7-bromobenzo[b]thiophene-2-carboxylate

Similarity: 0.84

Chemical Structure| 22913-24-2

[ 22913-24-2 ]

Methyl benzo[b]thiophene-2-carboxylate

Similarity: 0.83

Chemical Structure| 19397-74-1

[ 19397-74-1 ]

Ethyl 4,5-dihydronaphtho[1,2-b]thiophene-2-carboxylate

Similarity: 0.75

Chemical Structure| 20699-85-8

[ 20699-85-8 ]

Methyl 5-aminobenzo[b]thiophene-2-carboxylate

Similarity: 0.74

Related Parent Nucleus of
[ 360575-29-7 ]

Benzothiophenes

Chemical Structure| 360576-01-8

[ 360576-01-8 ]

Methyl 6-bromobenzo[b]thiophene-2-carboxylate

Similarity: 0.90

Chemical Structure| 550998-53-3

[ 550998-53-3 ]

Methyl 7-bromobenzo[b]thiophene-2-carboxylate

Similarity: 0.84

Chemical Structure| 22913-24-2

[ 22913-24-2 ]

Methyl benzo[b]thiophene-2-carboxylate

Similarity: 0.83

Chemical Structure| 6314-28-9

[ 6314-28-9 ]

Benzo[b]thiophene-2-carboxylic acid

Similarity: 0.77

Chemical Structure| 1467-86-3

[ 1467-86-3 ]

6-Methylbenzo[b]thiophene-2-carboxylic acid

Similarity: 0.77

; ;